EU–UKRAINE PHARMA DIALOGUE

The pharmaceutical sector in Ukraine and the EU is entering a period of significant regulatory change, creating new challenges and opportunities for companies operating across both markets.

EU–Ukraine Pharma Dialogue is a four-part event series exploring how evolving regulations affect pharmaceutical businesses, from market entry and clinical trials to competition, pricing and reimbursement.

Bringing together legal experts, regulators and industry representatives from Ukraine and the EU, the series goes beyond legislative updates to examine practical business implications, identify regulatory challenges and foster dialogue between the two markets.